tiprankstipranks
Trending News
More News >
Zylox-Tonbridge Medical Technology Co., Ltd. Class H (DE:818)
FRANKFURT:818
Germany Market

Zylox-Tonbridge Medical Technology Co., Ltd. Class H (818) Ratios

Compare
1 Followers

Zylox-Tonbridge Medical Technology Co., Ltd. Class H Ratios

DE:818's free cash flow for Q2 2025 was ¥0.71. For the 2025 fiscal year, DE:818's free cash flow was decreased by ¥ and operating cash flow was ¥0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.98 4.58 5.40 13.56 31.14
Quick Ratio
5.41 3.96 4.83 12.78 30.55
Cash Ratio
1.78 1.25 3.42 7.93 14.61
Solvency Ratio
0.75 0.37 -0.13 -0.55 -1.83
Operating Cash Flow Ratio
0.21 0.52 0.31 -0.60 -1.20
Short-Term Operating Cash Flow Coverage
1.12 2.00 1.97 0.00 0.00
Net Current Asset Value
¥ 1.60B¥ 1.18B¥ 1.39B¥ 1.90B¥ 2.92B
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.03 0.02 <0.01 <0.01
Debt-to-Equity Ratio
0.02 0.03 0.02 <0.01 <0.01
Debt-to-Capital Ratio
0.02 0.03 0.02 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.11 1.11 1.11 1.05 1.03
Debt Service Coverage Ratio
3.55 0.73 -0.81 -129.39 -634.68
Interest Coverage Ratio
0.00 28.01 -125.12 -288.64 -692.10
Debt to Market Cap
0.01 0.02 0.01 0.00 0.00
Interest Debt Per Share
0.20 0.29 0.17 0.04 0.03
Net Debt to EBITDA
-2.42 -5.01 24.77 13.76 6.76
Profitability Margins
Gross Profit Margin
72.14%71.55%72.95%75.63%74.13%
EBIT Margin
18.83%4.62%-14.68%-33.77%-122.63%
EBITDA Margin
20.39%8.34%-7.88%-25.91%-117.18%
Operating Profit Margin
18.92%7.78%-29.66%-62.38%-119.43%
Pretax Profit Margin
22.41%12.81%-14.92%-33.99%-112.24%
Net Profit Margin
23.12%12.81%-14.92%-33.99%-112.24%
Continuous Operations Profit Margin
23.12%12.81%-14.92%-33.99%-112.24%
Net Income Per EBT
103.20%100.00%100.00%100.00%100.00%
EBT Per EBIT
118.44%164.58%50.30%54.49%93.98%
Return on Assets (ROA)
6.78%2.90%-2.33%-3.49%-6.15%
Return on Equity (ROE)
7.59%3.23%-2.58%-3.67%-6.35%
Return on Capital Employed (ROCE)
6.10%1.95%-5.12%-6.72%-6.74%
Return on Invested Capital (ROIC)
5.99%1.90%-5.03%-6.70%-6.28%
Return on Tangible Assets
6.86%2.93%-2.34%-3.54%-6.20%
Earnings Yield
3.93%2.80%-2.12%-3.03%-3.26%
Efficiency Ratios
Receivables Turnover
47.12 508.43 446.49 329.48 398.91
Payables Turnover
4.69 3.21 3.36 4.46 2.13
Inventory Turnover
1.57 1.08 0.78 0.68 0.80
Fixed Asset Turnover
1.48 1.18 0.91 1.07 0.92
Asset Turnover
0.29 0.23 0.16 0.10 0.05
Working Capital Turnover Ratio
0.66 0.60 0.32 0.14 0.11
Cash Conversion Cycle
162.32 223.91 361.90 453.83 283.96
Days of Sales Outstanding
7.75 0.72 0.82 1.11 0.92
Days of Inventory Outstanding
232.35 336.95 469.59 534.56 454.13
Days of Payables Outstanding
77.78 113.75 108.51 81.83 171.09
Operating Cycle
240.10 337.67 470.41 535.66 455.05
Cash Flow Ratios
Operating Cash Flow Per Share
0.22 0.54 0.30 -0.28 -0.39
Free Cash Flow Per Share
<0.01 -0.05 -0.28 -0.72 -0.70
CapEx Per Share
0.22 0.59 0.58 0.44 0.30
Free Cash Flow to Operating Cash Flow
<0.01 -0.10 -0.94 2.59 1.77
Dividend Paid and CapEx Coverage Ratio
1.01 0.91 0.52 -0.63 -1.30
Capital Expenditure Coverage Ratio
1.01 0.91 0.52 -0.63 -1.30
Operating Cash Flow Coverage Ratio
1.10 1.91 1.76 -6.52 -12.36
Operating Cash Flow to Sales Ratio
0.07 0.22 0.19 -0.27 -0.65
Free Cash Flow Yield
<0.01%-0.48%-2.50%-6.32%-3.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
25.48 35.68 -47.06 -32.99 -30.64
Price-to-Sales (P/S) Ratio
5.92 4.57 7.02 11.21 34.39
Price-to-Book (P/B) Ratio
1.91 1.15 1.22 1.21 1.95
Price-to-Free Cash Flow (P/FCF) Ratio
10.21K -207.21 -40.07 -15.83 -29.73
Price-to-Operating Cash Flow Ratio
88.14 20.55 37.64 -41.02 -52.65
Price-to-Earnings Growth (PEG) Ratio
0.44 -0.16 1.60 0.66 -0.26
Price-to-Fair Value
1.91 1.15 1.22 1.21 1.95
Enterprise Value Multiple
26.59 49.77 -64.29 -29.51 -22.59
Enterprise Value
5.68B 3.25B 2.67B 2.55B 4.71B
EV to EBITDA
26.58 49.77 -64.29 -29.51 -22.59
EV to Sales
5.42 4.15 5.07 7.65 26.47
EV to Free Cash Flow
9.36K -188.26 -28.92 -10.80 -22.88
EV to Operating Cash Flow
81.09 18.67 27.17 -27.97 -40.52
Tangible Book Value Per Share
10.11 9.50 9.24 9.23 10.57
Shareholders’ Equity Per Share
10.11 9.59 9.27 9.37 10.67
Tax and Other Ratios
Effective Tax Rate
-0.03 0.00 0.00 -0.06 0.07
Revenue Per Share
3.28 2.42 1.61 1.01 0.60
Net Income Per Share
0.76 0.31 -0.24 -0.34 -0.68
Tax Burden
1.03 1.00 1.00 1.00 1.00
Interest Burden
1.19 2.77 1.02 1.01 0.92
Research & Development to Revenue
0.23 0.30 0.49 0.70 0.94
SG&A to Revenue
0.05 0.12 0.22 0.33 0.57
Stock-Based Compensation to Revenue
0.02 0.03 0.16 0.26 0.43
Income Quality
0.46 1.74 -1.25 0.80 0.58
Currency in CNY